We know that more can be done within our health plan offering as well for customers and patients as well as clinical partners ...

Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its ...

Cigna forecast annual profit below Wall Street expectations on Thursday and missed estimates for the fourth quarter, as ...

Cigna has deleveraged substantially after acquiring Express Scripts in late 2018 when Cigna's debt rose to over $42 billion, or debt/capital of 51%. Management has made good progress on its ...

CEO David Cordani highlighted Cigna's full-year revenue growth of $247 billion, a 27% increase, alongside adjusted EPS of $27.33, which fell short of expectations. He reaffirmed the company's ...

The Cigna Group reported today their total revenue of $247.1 billion for 2024, compared with $195.3 billion in 2023. This growth highlights the company’s strong financial results, supported by ...

Wall Street's main indexes rose on Thursday, driven by post-earnings advances in Meta and Tesla, although Microsoft's weak ...

Cigna Group CEO David Cordani said the company will make investments this year to improve patient and provider experiences ...

Cigna pulled in $1.4 billion in profit in Q4, a decrease that company officials say is due to elevated medical costs.

Deep-pocketed investors have adopted a bullish approach towards Cigna CI, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...

According to Bloomberg, a top Cigna executive said it will prevent patients from paying the full list price for drugs, or more than their employer has contributed.